V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20209738 | 20078131 | 1.71 | 69.9 | Curative (C) | 2018-01-26 | 2018-02-08 | Trial Unspecified | 02 | Y | TRIAL UNSPECIFIED | 100520149 |
| 20209740 | 20078132 | 1.7 | 86.2 | Palliative (P) | 2017-11-02 | 2017-11-08 | Capecitabine (21days) + Carboplatin | 02 | Y | DOXORUBICIN EMBOLISATION | 101080691 |
| 20209744 | 20078133 | 1.63 | 98 | Curative (C) | 2018-12-02 | 2018-12-24 | CISPLATIN + FLUOROURACIL | null | N | CISPLATIN + FLUOROURACIL | 100444819 |
| 20209752 | 20078134 | 1.63 | 74.5 | Palliative (P) | 2017-10-08 | 2017-10-21 | Cisplatin +Fluorouracil (3 wk) | null | N | CISPLATIN + FLUOROURACIL | 100343797 |
| 20209760 | 20078135 | 1.78 | 74.6 | Curative (C) | 2020-03-20 | 2020-03-27 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100619011 |
| 20209766 | 20078136 | null | 45.6 | Curative (C) | 2016-08-06 | 2016-08-06 | Capecitabine (21days) + Carboplatin | 2 | Y | DOXORUBICIN EMBOLISATION | 100584141 |
| 20209769 | 20078137 | 1.58 | 66.5 | Curative (C) | 2016-09-22 | 2016-09-25 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 100723397 |
| 20209773 | 20078138 | 1.66 | 91.1 | Curative (C) | 2016-08-11 | 2016-08-12 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | CISPLATIN + FLUOROURACIL | 100265066 |
| 20209775 | 20078139 | 1.74 | 73 | Curative (C) | 2017-06-04 | 2017-06-04 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101634766 |
| 20209778 | 20078140 | 1.8 | 71.2 | Neo-adjuvant (N) | 2019-05-28 | 2019-06-26 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101755375 |
| 20209779 | 20078141 | 1.61 | 97.9 | Palliative (P) | 2019-08-04 | 2019-08-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101050753 |
| 20209781 | 20078142 | null | 78 | Curative (C) | null | 2020-03-06 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100815307 |
| 20209784 | 20078143 | 0 | 0 | Palliative (P) | 2016-02-15 | 2016-03-05 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100645612 |
| 20209790 | 20078144 | 1.68 | 80.4 | Palliative (P) | 2017-12-09 | 2018-01-21 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101155492 |
| 20209794 | 20078145 | 1.61 | 90.6 | Palliative (P) | 2017-03-16 | 2017-03-31 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101380848 |
| 20209798 | 20078146 | 1.74 | 88.5 | Curative (C) | 2016-10-01 | 2016-10-27 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101849799 |
| 20209799 | 20078147 | null | null | Palliative (P) | 2016-05-08 | 2016-05-28 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100615090 |
| 20209802 | 20078148 | 1.86 | 80.65 | Palliative (P) | 2019-09-22 | 2019-10-07 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100674014 |
| 20209803 | 20078149 | 1.62 | 60.2 | Palliative (P) | null | 2016-05-07 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101174660 |
| 20209807 | 20078150 | 1.67 | 72.5 | Neo-adjuvant (N) | 2019-08-30 | 2019-09-24 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101870209 |
| 20209813 | 20078151 | 1.62 | 79.2 | null | null | 2017-01-23 | CAPECITABINE + CARBOPLATIN | 02 | null | DOXORUBICIN EMBOLISATION | 101671570 |
| 20209814 | 20078152 | 1.79 | 65.5 | Palliative (P) | 2018-11-26 | 2018-11-26 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 101350511 |
| 20209815 | 20078153 | 1.59 | 65 | Curative (C) | 2017-05-30 | 2017-06-03 | CAPECITABINE + CARBOPLATIN | N | Y | TRIAL UNSPECIFIED | 101796463 |
| 20209816 | 20078154 | 1.71 | 42.5 | Palliative (P) | 2016-09-14 | 2016-09-27 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101841419 |
| 20209820 | 20078155 | 1.53 | 115.4 | Neo-adjuvant (N) | 2017-08-02 | 2017-08-12 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101482780 |
| 20209826 | 20078156 | 1.85 | 57.3 | null | 2019-09-14 | 2019-09-17 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101714058 |
| 20209829 | 20078157 | 0 | 0 | null | 2021-06-30 | 2021-07-27 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101650597 |
| 20209831 | 20078158 | 1.71 | 99.1 | Neo-adjuvant (N) | 2019-10-01 | 2019-10-10 | Capecitabine (21days) + Carboplatin | 2 | null | TRIAL UNSPECIFIED | 100702545 |
| 20209837 | 20078159 | 1.6 | 99 | Curative (C) | 2017-10-16 | 2017-10-27 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100021159 |
| 20209838 | 20078160 | 1.71 | 51.1 | Palliative (P) | 2018-11-08 | 2018-11-22 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101741667 |
| 20209839 | 20078161 | 0 | 0 | Neo-adjuvant (N) | 2018-06-24 | 2018-06-25 | Capecitabine + Carboplatin + RT | 2 | Y | DOXORUBICIN EMBOLISATION | 101446103 |
| 20209840 | 20078162 | 0 | 0 | null | 2017-04-30 | 2017-05-14 | Doxorubicin chemoembolisation | null | null | DOXORUBICIN EMBOLISATION | 100975261 |
| 20209843 | 20078163 | 1.66 | 58 | Neo-adjuvant (N) | 2016-09-12 | 2016-09-12 | Capecitabine + Carboplatin + RT | N | N | CAPECITABINE + CARBOPLATIN | 101139270 |
| 20209849 | 20078164 | 1.7 | 67.5 | Curative (C) | 2016-03-03 | 2016-03-20 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101042351 |
| 20209851 | 20078165 | 0 | 0 | null | 2019-12-22 | 2020-01-05 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 101446702 |
| 20209855 | 20078166 | 1.76 | 52.4 | Neo-adjuvant (N) | 2018-05-19 | 2018-05-31 | Capecitabine (21days) + Carboplatin | N | N | TRIAL UNSPECIFIED | 101850503 |
| 20209858 | 20078167 | 1.64 | 71.8 | Palliative (P) | 2017-01-11 | 2017-01-17 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 101737984 |
| 20209867 | 20078168 | 1.72 | 48 | null | 2018-05-09 | 2018-05-10 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101858690 |
| 20209870 | 20078169 | 1.78 | 76.9 | Palliative (P) | 2019-07-03 | 2019-07-08 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101539010 |
| 20209879 | 20078170 | 1.56 | 182 | Palliative (P) | 2017-12-28 | 2017-12-28 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100953022 |
| 20209885 | 20078171 | 0 | 0 | null | 2017-06-08 | 2017-06-08 | CAPECITABINE + CARBOPLATIN | 02 | null | DOXORUBICIN EMBOLISATION | 101533031 |
| 20209888 | 20078172 | 1.74 | 99.6 | null | 2018-09-16 | 2018-09-16 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100454398 |
| 20209891 | 20078173 | 1.68 | 71.8 | Palliative (P) | 2016-04-15 | 2016-04-28 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100650861 |
| 20209895 | 20078174 | null | null | null | 2019-10-30 | 2019-11-13 | Doxorubicin chemoembolisation | null | null | DOXORUBICIN EMBOLISATION | 100641023 |
| 20209896 | 20078175 | 1.76 | 87.35 | Curative (C) | 2019-01-02 | 2019-01-03 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 100605625 |
| 20209900 | 20078176 | 1.84 | 46.9 | Palliative (P) | 2019-07-31 | 2019-09-09 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101761255 |
| 20209902 | 20078177 | 1.68 | 91.8 | Curative (C) | 2019-06-24 | 2019-07-01 | Capecitabine (21days) + Carboplatin | 02 | null | DOXORUBICIN EMBOLISATION | 100492349 |
| 20209905 | 20078178 | 1.52 | 84.3 | Neo-adjuvant (N) | null | 2021-02-28 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101275038 |
| 20209907 | 20078179 | 1.72 | 80 | Curative (C) | 2017-12-24 | 2017-12-27 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101787960 |
| 20209917 | 20078180 | null | 81.2 | Palliative (P) | 2019-12-13 | 2019-12-20 | CISPLATIN + FLUOROURACIL + RT | 2 | N | CISPLATIN + FLUOROURACIL | 100547280 |